201 related articles for article (PubMed ID: 38611938)
21. Curcumin therapeutic promises and bioavailability in colorectal cancer.
Shehzad A; Khan S; Shehzad O; Lee YS
Drugs Today (Barc); 2010 Jul; 46(7):523-32. PubMed ID: 20683505
[TBL] [Abstract][Full Text] [Related]
22. Curcumin: therapeutical potential in ophthalmology.
Pescosolido N; Giannotti R; Plateroti AM; Pascarella A; Nebbioso M
Planta Med; 2014 Mar; 80(4):249-54. PubMed ID: 24323538
[TBL] [Abstract][Full Text] [Related]
23. Curcumin in Cancer and Inflammation: An In-Depth Exploration of Molecular Interactions, Therapeutic Potentials, and the Role in Disease Management.
Moon DO
Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474160
[TBL] [Abstract][Full Text] [Related]
24. Pharmacokinetics, Pharmacodynamics, and PKPD Modeling of Curcumin in Regulating Antioxidant and Epigenetic Gene Expression in Healthy Human Volunteers.
Cheng D; Li W; Wang L; Lin T; Poiani G; Wassef A; Hudlikar R; Ondar P; Brunetti L; Kong AN
Mol Pharm; 2019 May; 16(5):1881-1889. PubMed ID: 30860383
[TBL] [Abstract][Full Text] [Related]
25. Curcumin and neurodegenerative diseases: a perspective.
Darvesh AS; Carroll RT; Bishayee A; Novotny NA; Geldenhuys WJ; Van der Schyf CJ
Expert Opin Investig Drugs; 2012 Aug; 21(8):1123-40. PubMed ID: 22668065
[TBL] [Abstract][Full Text] [Related]
26. Use of curcumin and its nanopreparations in the treatment of inflammatory bowel disease.
Meng ZW; Chang B; Sang LX
World J Gastroenterol; 2024 Jan; 30(3):280-282. PubMed ID: 38314128
[TBL] [Abstract][Full Text] [Related]
27. Nanotechnology and curcumin: a novel and promising approach in digestive cancer therapy.
Zhang Y; Li Z; Huang Y; Xu Y; Zou B
Nanomedicine (Lond); 2023 Nov; 18(27):2081-2099. PubMed ID: 38078442
[TBL] [Abstract][Full Text] [Related]
28. Therapeutic Potential of Curcumin for the Treatment of Brain Tumors.
Klinger NV; Mittal S
Oxid Med Cell Longev; 2016; 2016():9324085. PubMed ID: 27807473
[TBL] [Abstract][Full Text] [Related]
29. Bioactive Effects of Curcumin in Human Immunodeficiency Virus Infection Along with the Most Effective Isolation Techniques and Type of Nanoformulations.
Butnariu M; Quispe C; Koirala N; Khadka S; Salgado-Castillo CM; Akram M; Anum R; Yeskaliyeva B; Cruz-Martins N; Martorell M; Kumar M; Vasile Bagiu R; Abdull Razis AF; Sunusi U; Muhammad Kamal R; Sharifi-Rad J
Int J Nanomedicine; 2022; 17():3619-3632. PubMed ID: 35996526
[TBL] [Abstract][Full Text] [Related]
30. Effect of nano-curcumin on various diseases: A comprehensive review of clinical trials.
Hassanizadeh S; Shojaei M; Bagherniya M; Orekhov AN; Sahebkar A
Biofactors; 2023; 49(3):512-533. PubMed ID: 36607090
[TBL] [Abstract][Full Text] [Related]
31. Therapeutic potential of curcumin in digestive diseases.
Dulbecco P; Savarino V
World J Gastroenterol; 2013 Dec; 19(48):9256-70. PubMed ID: 24409053
[TBL] [Abstract][Full Text] [Related]
32. Curcumin: a boon to colonic diseases.
Sareen R; Jain N; Pandit V
Curr Drug Targets; 2013 Sep; 14(10):1210-8. PubMed ID: 23768171
[TBL] [Abstract][Full Text] [Related]
33. The Holy Grail of Curcumin and its Efficacy in Various Diseases: Is Bioavailability Truly a Big Concern?
Toden S; Goel A
J Restor Med; 2017 Dec; 6(1):27-36. PubMed ID: 30899605
[TBL] [Abstract][Full Text] [Related]
34. Curcumin: the potential for efficacy in gastrointestinal diseases.
Irving GR; Karmokar A; Berry DP; Brown K; Steward WP
Best Pract Res Clin Gastroenterol; 2011 Aug; 25(4-5):519-34. PubMed ID: 22122768
[TBL] [Abstract][Full Text] [Related]
35. Curcumin as a therapeutic agent in leukemia.
Kouhpeikar H; Butler AE; Bamian F; Barreto GE; Majeed M; Sahebkar A
J Cell Physiol; 2019 Aug; 234(8):12404-12414. PubMed ID: 30609023
[TBL] [Abstract][Full Text] [Related]
36. Curcumin, the active substance of turmeric: its effects on health and ways to improve its bioavailability.
Abd El-Hack ME; El-Saadony MT; Swelum AA; Arif M; Abo Ghanima MM; Shukry M; Noreldin A; Taha AE; El-Tarabily KA
J Sci Food Agric; 2021 Nov; 101(14):5747-5762. PubMed ID: 34143894
[TBL] [Abstract][Full Text] [Related]
37. Preparation and characterization of a solid dispersion containing curcumin and octenylsuccinate hydroxypropyl phytoglycogen for improved curcumin solubility.
Xie Y; Yao Y
Eur J Pharm Sci; 2020 Oct; 153():105462. PubMed ID: 32652196
[TBL] [Abstract][Full Text] [Related]
38. Advances in β-Diketocyclisation of Curcumin Derivatives and their Antitumor Activity.
Dai H; Zhang S; Zheng X; Luo Z; Chen H; Yao X
Chem Biodivers; 2024 Feb; 21(2):e202301556. PubMed ID: 38095134
[TBL] [Abstract][Full Text] [Related]
39. Curcumin's spice-infused therapeutic promise: disease severity alleviation in a mouse model of multiple sclerosis via modulation of immune responses.
Amiri Z; Jalili S; Tarahomi M; Eslami M; Yazdanpanah E; Baharlou R; Esmaeili SA; Yousefi B; Haghmorad D
Mol Biol Rep; 2023 Nov; 50(11):8843-8853. PubMed ID: 37660318
[TBL] [Abstract][Full Text] [Related]
40. Nanotechnology-applied curcumin for different diseases therapy.
Ghalandarlaki N; Alizadeh AM; Ashkani-Esfahani S
Biomed Res Int; 2014; 2014():394264. PubMed ID: 24995293
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
